SPRY2 and neoplasm: MiR-27a reduces SPRY2 and FOXO3 in U87 GB cells, but the inhibition of miR-27a impairs the proliferation of U87 cells and the tumor growth of U87 cells in subcutaneous mouse tumor xenografts, in which SPRY2 and FOXO3 are increased [92].